4083111 — Romosozumab 210mg/2.34 Ml Solution[pres}
Cite this view
HANK Price Transparency. (n.d.). Romosozumab 210mg/2.34 Ml Solution[pres} (CDM 4083111) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/4083111?code_type=CDM
“Romosozumab 210mg/2.34 Ml Solution[pres} (CDM 4083111) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/4083111?code_type=CDM. Accessed .
“Romosozumab 210mg/2.34 Ml Solution[pres} (CDM 4083111) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/4083111?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $7,536–$8,991 (25th–75th percentile) across 1 hospital · 3 payers.
“Negotiated” is the hospital’s negotiated facility rate for this CDM 4083111 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| PRESENTATION MEDICAL CENTER Both | NextBlue | Medicare Advantage | $6,082.00 | $9,464.00 | $8,518.00 | 2026-05-27 | MRF ↗ |
| PRESENTATION MEDICAL CENTER Both | Sanford Health Plan | Commercial | $8,991.00 | $9,464.00 | $8,518.00 | 2026-05-27 | MRF ↗ |
| PRESENTATION MEDICAL CENTER Both | HealthPartners | Commercial | $8,991.00 | $9,464.00 | $8,518.00 | 2026-05-27 | MRF ↗ |